Molecular Templates, Inc.
MTEM
MTEM was delisted on the 24th of December, 2024.
86 hedge funds and large institutions have $249M invested in Molecular Templates, Inc. in 2021 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 23 increasing their positions, 27 reducing their positions, and 14 closing their positions.
68% more call options, than puts
Call options by funds: $315K | Put options by funds: $188K
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
3% less funds holding
Funds holding: 89 → 86 (-3)
9% less capital invested
Capital invested by funds: $275M → $249M (-$25.9M)
14% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 14
15% less repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 27
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$8.59M |
| 2 |
Renaissance Technologies
New York
|
+$1.45M |
| 3 |
Two Sigma Investments
New York
|
+$1.35M |
| 4 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
+$724K |
| 5 |
Morgan Stanley
New York
|
+$532K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
-$1.56M |
| 2 |
Charles Schwab
San Francisco,
California
|
-$1.22M |
| 3 |
ECM
Endurant Capital Management
San Mateo,
California
|
-$924K |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$614K |
| 5 |
JP Morgan Chase
New York
|
-$418K |
MTEM Hedge Fund Activity: Q3 2021 in Review
86 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Molecular Templates, Inc. (MTEM) for Q3 2021, worth a combined $249M — down 9.4% from $275M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of MTEM and 12 opened new positions — a net loss of 2 holders — while 27 trimmed existing stakes and 23 added.
The largest buyer was Bellevue Group, adding an estimated $8.59M. The largest seller was Tekla Capital Management, exiting entirely with an estimated $1.56M sold.
- 86 institutional investors held Molecular Templates, Inc. (MTEM) as of Q3 2021, down from 89 in Q2 2021.
- Funds reported $249M of Molecular Templates, Inc. stock for Q3 2021, down 9.4% quarter-over-quarter.
- 12 funds opened new Molecular Templates, Inc. positions in Q3 2021 and 14 closed out, a net change of -2 holders.
- The largest Molecular Templates, Inc. buyer in Q3 2021 was Bellevue Group, an estimated $8.59M added.
- The largest Molecular Templates, Inc. seller in Q3 2021 was Tekla Capital Management, an estimated $1.56M sold.
Based on aggregated 13F filings for Q3 2021.